Correlation Between Larimar Therapeutics and Absci Corp

Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Larimar Therapeutics and Absci Corp, you can compare the effects of market volatilities on Larimar Therapeutics and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Absci Corp.

Diversification Opportunities for Larimar Therapeutics and Absci Corp

0.02

Correlation Coefficient

Larimar Therapeutics  Absci Corp

Significant diversification

The 3 months correlation between Larimar and Absci is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Absci Corp go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Absci Corp

Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Absci Corp. But the stock apears to be less risky and, when comparing its historical volatility, Larimar Therapeutics is 1.58 times less risky than Absci Corp. The stock trades about -0.15 of its potential returns per unit of risk. The Absci Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  277.00  in Absci Corp on December 27, 2024 and sell it today you would earn a total of  13.00  from holding Absci Corp or generate 4.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Larimar Therapeutics  vs.  Absci Corp

Larimar Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Absci Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Absci Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Absci Corp demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Larimar Therapeutics and Absci Corp

The main advantage of trading using opposite Larimar Therapeutics and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.

The idea behind Larimar Therapeutics and Absci Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.